Delivery Order SPE2DB22D1103-SPE2DB25FTLA2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 29, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for supply of Vyndamax 61 mg capsule unit dose packages (30-count). This is a firm fixed price, non-set-aside contract with a completion deadline of August 26, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packs (30-count) on August 15, 2025, with a completion date of September 8, 2025. The contract uses firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). The contract, issued under firm fixed pricing with no set-aside designation, is scheduled for completion by September 24, 2025, and represents a competitive award to support federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules (30-count unit dose) with a completion date of November 24, 2025. This non-competitive delivery order represents a firm fixed price transaction issued under the company's existing pharmaceutical supply contract with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on May 12, 2025, with a completion date of June 3, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major supplier of...
- The Defense Logistics Agency awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This competitively awarded, firm fixed-price delivery order is set to be completed by November 21, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $55,387.88 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Vyndamax 61 mg capsule unit dose packs (30-count). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 20, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical distributor...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules in unit dose packaging (30-count). The contract, awarded on September 12, 2025, with completion targeted for October 3, 2025, utilizes firm fixed price terms with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This competitively awarded, firm fixed-price contract is scheduled for completion by November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this order was open to competition and reflects the agency's...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTLA2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of May 14, 2025. The award is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's major pharmaceutical distributors and a critical federal medical procurement vendor. The company maintains an extensive portfolio of federal contract awards with the DLA Medical Supply Chain, delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's federal contracting history demonstrates consistent capability to meet procurement requirements through open competition, with delivery orders ranging from minimal to substantial values and utilizing firm fixed pricing structures to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 4/23/25 |